FindTrial
Sign In

Study of Samata in Amavata vyadhi and its relationship with Neutrophil Lymphocyte Ratio

A Study on the association of Samata in Amavata vyadhi and Neutrophil Lymphocyte Ratio A cross Sectional study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/01/102586
Enrollment
60
Registered
2026-01-30
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M069- Rheumatoid arthritis, unspecified

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

Dr Pradip Dagduba Ukharde
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed patients of Amavata will be selected. Patients between 18 to 50 years of age will be selected. Patients will be selected regardless of their gender religion occupation or socio-economic status.

Exclusion criteria

Exclusion criteria: Patients with a history of trauma. Individuals suffering from systemic disorders such as Hypertension or Diabetes mellitus. Pregnant Women and lactating mother. Patients who have rheumatic fever or gout will not be taken for the study. patient with history of malignancy patient suffering from any acute or chronic infections disease (e.g. Tuberculosis Viral Hepatitis HIV Urinary Tract Infection).

Design outcomes

Primary

MeasureTime frame
To study Association of Samata in Amavata Vyadhi and Neutrophil -lymphocyte Ratio(NLR)Timepoint: At enrollment—

Secondary

MeasureTime frame
To study Nidanpanchank of Amavat Vyadhi in detail. To Study concept of Ama in detail.Timepoint: At enrollment—

Countries

India

Contacts

Public ContactDr Pradip Dagduba Ukharde

Radhakisan Toshniwal Ayurved Mahavidyalaya Akola

upadhyaydrsapna@gmail.com8275287035

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026